Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Pharmaceutical Firms will adopt Backward Districts in India
Jan 05, 2007
Indian pharmaceutical companies may soon adopt the backward districts in the country. The companies plan to create drug banks and cater to the healthcare needs of the populace living in such areas.
Department of chemicals and petrochemicals, as part of the first-ever public private endeavor of this type, is working out a plan for BPL (Below Poverty Line) families. A pilot project beginning on 26 January 2007 will envisage the manufacture of about 600 drug banks. The project will include two to three districts from each state that is a part of this program.
Underlining that the scheme will need three way cooperation amongst the state governments, makers of drugs, and central govt., a senior officer said, “Although the state and this dept will offer a one time funding of INR 15 lakh as seed money to a drug bank in each of the district, the pharmaceutical firm (that will adopt that specific district) will also bring in a similar amount. The amount can be either in the form of drugs or in cash.
Drug banks, which will be set up on the lines of medicare societies inside Rajasthan’s district hospitals, will procure drugs from foster pharmaceutical firms and sell it at 50% discount to district population at large and for free to the families living below poverty line.
Another important component of the adoption strategy involves a pharmaceutical firm conducting minimum six free medical camps per year in its adopted district, with the overheads being taken care of by the company and the state govt. pitching in by way of medical staff.
As per a Research Analyst’s view at RNCOS, who has recently researched a report on “World Pharmaceutical Market (2007)”, “These kinds of a combined endeavors by the govt. and non-govt. firms will no doubt help spur the growth of the world pharmaceutical industry in the years to come.”
The research report on “World Pharmaceutical Market (2007)" also addresses the issues and facts that are critical to the success of Pharmaceutical industry on a Global level.
- The emerging trends in the Global Pharmaceutical sector.
- Who are the key players in the Pharmaceutical market?
- Get an insight into the trends in market performance.
- Pinpoint sectors of growth and identify driving factors.
- Identify market, brand leaders, and understand the competitive environment.
- Key Challenges and Strategies.
About the report
The report further provides an extensive overview of Pharmaceutical industry on a worldwide level. It provides authentic past and current performance data for the Pharmaceutical industry and looks closely at the various issues relevant to the industry.
For more information visit: http://www.rncos.com/Report/IM085.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Novel Parkinson Disease Drugs Aid in Reducing “Off” Time in Patients
- Nanotechnology Mediated Targeted Drug Delivery for Cancer Treatment: Gaining Momentum
- Stem Cell Therapy – A Breakthrough in Parkinson’s Disease Treatment
- Lentiviral Vectors: Emerging as a Promising Tool for T-Cell Immunotherapy
- Nanosized Drug Delivery Systems Revolutionizing Entire Drug Therapy Strategy
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact